Greg Wolf to Cytokines
This is a "connection" page, showing publications Greg Wolf has written about Cytokines.
Connection Strength
1.016
-
Wolf GT, Liu S, Bellile E, Sartor M, Rozek L, Thomas D, Nguyen A, Zarins K, McHugh JB. Tumor infiltrating lymphocytes after neoadjuvant IRX-2 immunotherapy in oral squamous cell carcinoma: Interim findings from the INSPIRE trial. Oral Oncol. 2020 12; 111:104928.
Score: 0.510
-
Wolf GT, Fee WE, Dolan RW, Moyer JS, Kaplan MJ, Spring PM, Suen J, Kenady DE, Newman JG, Carroll WR, Gillespie MB, Freeman SM, Baltzer L, Kirkley TD, Brandwein HJ, Hadden JW. Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head Neck. 2011 Dec; 33(12):1666-74.
Score: 0.264
-
Russo N, Bellile E, Murdoch-Kinch CA, Liu M, Eisbruch A, Wolf GT, D'Silva NJ. Cytokines in saliva increase in head and neck cancer patients after treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Oct; 122(4):483-490.e1.
Score: 0.096
-
Shkeir O, Athanassiou-Papaefthymiou M, Lapadatescu M, Papagerakis P, Czerwinski MJ, Bradford CR, Carey TE, Prince ME, Wolf GT, Papagerakis S. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas. Head Neck. 2013 Nov; 35(11):1542-50.
Score: 0.076
-
Getz KR, Bellile E, Zarins KR, Chinn SB, Taylor JMG, Rozek LS, Wolf GT, Mondul AM. The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma. Head Neck. 2022 06; 44(6):1393-1403.
Score: 0.036
-
Liu S, Bellile E, Nguyen A, Zarins K, D'Silva N, Rozek L, Wolf GT, Sartor MA. Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen. Oral Oncol. 2021 12; 123:105587.
Score: 0.035